US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Zurich Insurance Group Ag (0QP2) 銘柄情報

Zurich Insurance Group Ag (0QP2)

0.00

0.00

(0.00%)

終了 7月11日 12:30AM

Zurich Insurance Group Ag (0QP2) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

平均取引量 (3 か月)

CHF 282,429

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

125.209B

前日終値

-

始値

-

時刻

最終取引時間

VWAP

-

歳入

73.08B

純利益

6.8B

発行済株式数

149,369,269

浮動株比率 (%)

99.82%

機関投資家保有比率 (%)

26.28%

配当利回り

PER

15.98

株価売上高倍率 (PSR)

1.54

1 株当たり利益 (EPS)

47.2

ベータ

0.32

Zurich Insurance Group AG provides insurance products and related services in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. It operates through Property & Casualty Regions, Life Regions, and Farmers segments. The company offers car and motor, home, travel, gene... Zurich Insurance Group AG provides insurance products and related services in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. It operates through Property & Casualty Regions, Life Regions, and Farmers segments. The company offers car and motor, home, travel, general liability, life and critical illness, and other insurance products; and saving and investment, and pension and retirement planning products. It also provides property, casualty, energy and engineering lines, and marine; management liability, financial institutions, and professional indemnity; and cyber, accident and health, and credit lines and surety insurance products, as well as non-claims and ancillary services to the farmers exchanges. In addition, it offers employee benefit insurance products; and climate resilience, risk engineering, captive, cyber resilience, and reinsurance services. It serves individuals, small businesses, mid-sized and large companies, and multinational corporations. The company sells its products through agents, brokers, and bank distribution channels. Zurich Insurance Group AG was founded in 1872 and is based in Zurich, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.zurich.com

本社

Zurich, Switzerland

設立

1872

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0QP2 - Frequently Asked Questions (FAQ)

What is the current Zurich Insurance Group Ag share price?

The current share price of Zurich Insurance Group Ag is CHF 0.00

How many Zurich Insurance Group Ag shares are in issue?

Zurich Insurance Group Ag has 149,369,269 shares in issue

What is the 1 year trading range for Zurich Insurance Group Ag share price?

Zurich Insurance Group Ag has traded in the range of CHF 0.00 to CHF 0.00 during the past year

What is the PE ratio of Zurich Insurance Group Ag?

The price to earnings ratio of Zurich Insurance Group Ag is 15.98

What is the cash to sales ratio of Zurich Insurance Group Ag?

The cash to sales ratio of Zurich Insurance Group Ag is 1.54

What is the registered address of Zurich Insurance Group Ag?

The registered address for Zurich Insurance Group Ag is Mythenquai 2, Zurich, Zurich, 8002

What is the Zurich Insurance Group Ag website address?

The website address for Zurich Insurance Group Ag is www.zurich.com

Twiggs333

Twiggs333 7分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 9分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 12分前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 21分前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 32分前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 38分前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 39分前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 41分前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

Non-promotional information until there is a press release is a wise move.

CatfishHunter

CatfishHunter 43分前

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

Philosophical Trader

Philosophical Trader 44分前

How is this doing? This was a great runner with a 2 year cup and handle.

nwtf

You really dont have a clue what you are talking about. Just stop.

rakp

What do you think BB? Are there any official OTCMarkets notifications/filings and what's this CCLX price of .50 cents? This looks to good to be true.

Doc logic

Doc logic 46分前

Galzus Research,

What if the end game is a friendly or two to the shorts were to bid for control at the lowest price possible before full Flaskworks validation or the value of Direct can be fully factored in by most investors while NWBO is still on the OTC? Just wondering. Best wish

ace65

WOW...game changer!!Thanks for sharing

nwtf

LOL LOL LOL LOL

IOW they didnt offer the money they wanted.

Whalatane

Whalatane 49分前

I'm having trouble understanding your reasoning here ....but I'll blame that on the Cabernet I'm drinking :--)

AMRN old timers may remember the polls poster Raf would put up ...thats what we need .

I'll go with your statement " I'm with Stumble and Ernie "
My p

RRP60

What colors of goat are you talking. He is a long and he is voicing his opinions as a long investor. I forgot what are you here, are you a bear, nelly, ha, i forgot you are an investor advocate. Dont you worry a bit, one day your buddy AF will face music from the law. Lets see how all of it will pla

Zurich Insurance

Alligator Energy (PK)

Arianne Phosphate

0.375% until19may2026

Planet Ventures

Invesco Capital Management

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。